Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Protect Audiology Licensure in Utah
The Utah Office of Professional Licensure Review (OPLR) has recommended a drastic change that would eliminate professional licensure for audiologists and speech-language pathologists and replace…
Government Re-Opening: What It Means for Hearing Health
After weeks of uncertainty, Congress has reached an agreement and is expected to vote later today on a continuing resolution to reopen the federal government…
Submit Your Poster Now
Join us in curating an annual convention program that amplifies the value of the profession. The AAA 2026 Program Committee is proud to invite clinicians,…


